| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
28,528 |
21,190 |
$3.91M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
39,592 |
31,158 |
$3.19M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
48,574 |
38,322 |
$3.02M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,484 |
2,749 |
$1.16M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,237 |
3,279 |
$592K |
| G0378 |
Hospital observation service, per hour |
2,953 |
2,216 |
$480K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
22,506 |
6,111 |
$385K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,360 |
7,433 |
$347K |
| 71046 |
Radiologic examination, chest; 2 views |
10,310 |
8,145 |
$329K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
8,695 |
3,277 |
$329K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,031 |
2,555 |
$316K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,496 |
3,568 |
$300K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,437 |
4,513 |
$285K |
| 80053 |
Comprehensive metabolic panel |
45,624 |
34,524 |
$278K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,036 |
802 |
$272K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,266 |
974 |
$234K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,890 |
2,221 |
$229K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
903 |
715 |
$223K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,124 |
3,349 |
$215K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,651 |
5,833 |
$212K |
| 90791 |
Psychiatric diagnostic evaluation |
4,444 |
2,677 |
$208K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,069 |
1,411 |
$206K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,034 |
32,577 |
$196K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
12,451 |
3,696 |
$189K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
461 |
375 |
$186K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,103 |
863 |
$184K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,624 |
8,583 |
$182K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,961 |
4,526 |
$167K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,522 |
1,264 |
$167K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,650 |
3,659 |
$119K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
653 |
489 |
$110K |
| 84443 |
Thyroid stimulating hormone (TSH) |
10,420 |
8,475 |
$108K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,658 |
1,252 |
$107K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,707 |
1,445 |
$107K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,610 |
3,140 |
$99K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
406 |
330 |
$98K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,819 |
4,102 |
$97K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,809 |
4,094 |
$96K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
525 |
403 |
$87K |
| 71045 |
Radiologic examination, chest; single view |
4,628 |
3,464 |
$83K |
| 97161 |
|
2,182 |
1,715 |
$83K |
| 96376 |
|
1,817 |
1,114 |
$82K |
| 80061 |
Lipid panel |
8,251 |
6,927 |
$79K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,354 |
1,176 |
$77K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,454 |
2,867 |
$74K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,437 |
2,849 |
$69K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,903 |
2,507 |
$66K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
295 |
237 |
$65K |
| 74018 |
|
1,763 |
1,338 |
$62K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,443 |
2,974 |
$60K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,681 |
1,474 |
$60K |
| 97162 |
|
1,510 |
1,177 |
$58K |
| 73630 |
|
1,743 |
1,405 |
$58K |
| 93351 |
|
341 |
281 |
$57K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,630 |
1,285 |
$54K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,375 |
1,961 |
$54K |
| 73610 |
|
1,427 |
1,171 |
$52K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
577 |
461 |
$52K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,334 |
2,056 |
$49K |
| 72100 |
|
1,227 |
985 |
$49K |
| 93971 |
|
1,023 |
799 |
$46K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,047 |
8,629 |
$45K |
| 71250 |
|
543 |
431 |
$45K |
| 84484 |
|
9,879 |
5,524 |
$44K |
| 83690 |
|
11,189 |
8,578 |
$44K |
| 73562 |
|
1,290 |
1,027 |
$43K |
| 73130 |
|
953 |
781 |
$43K |
| 85027 |
|
9,851 |
7,622 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,984 |
2,109 |
$42K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,168 |
1,382 |
$41K |
| 59050 |
|
1,168 |
748 |
$41K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,812 |
1,596 |
$37K |
| 84703 |
|
7,091 |
5,588 |
$34K |
| 76775 |
|
500 |
382 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,471 |
4,660 |
$31K |
| 73030 |
|
1,080 |
831 |
$30K |
| 76830 |
Ultrasound, transvaginal |
385 |
304 |
$30K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
128 |
102 |
$29K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,437 |
3,637 |
$29K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
227 |
148 |
$27K |
| 73110 |
|
752 |
603 |
$27K |
| 83880 |
|
1,816 |
1,341 |
$27K |
| 76642 |
|
498 |
376 |
$25K |
| 84702 |
|
2,127 |
1,359 |
$24K |
| 74019 |
|
623 |
507 |
$23K |
| 59025 |
Fetal non-stress test |
1,032 |
629 |
$23K |
| 87040 |
|
2,430 |
1,513 |
$21K |
| 82728 |
|
2,150 |
1,775 |
$21K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
449 |
358 |
$21K |
| 86850 |
|
2,701 |
2,080 |
$20K |
| 87077 |
|
3,430 |
2,568 |
$20K |
| 97035 |
|
1,930 |
709 |
$19K |
| 87081 |
|
4,135 |
3,243 |
$19K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
72 |
57 |
$19K |
| 87186 |
|
3,085 |
2,303 |
$19K |
| 85730 |
|
5,749 |
4,390 |
$18K |
| 86803 |
|
1,835 |
1,493 |
$18K |
| 76536 |
|
289 |
239 |
$18K |
| 81001 |
|
10,079 |
7,691 |
$17K |
| 87070 |
|
2,713 |
2,256 |
$17K |
| 82607 |
|
2,078 |
1,671 |
$17K |
| 84439 |
|
2,667 |
2,169 |
$17K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,705 |
1,444 |
$16K |
| 82657 |
|
1,265 |
1,050 |
$16K |
| 83721 |
|
2,577 |
2,248 |
$16K |
| 85610 |
|
7,368 |
5,277 |
$16K |
| 88342 |
|
1,208 |
954 |
$14K |
| 87808 |
|
1,268 |
1,051 |
$14K |
| J2704 |
Injection, propofol, 10 mg |
6,031 |
4,085 |
$14K |
| 83735 |
|
3,562 |
2,396 |
$13K |
| 87340 |
|
1,745 |
1,451 |
$13K |
| 94060 |
|
224 |
178 |
$13K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
711 |
460 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
23,065 |
14,012 |
$12K |
| 70486 |
|
57 |
49 |
$11K |
| 70496 |
|
42 |
26 |
$11K |
| 76770 |
|
99 |
80 |
$11K |
| 87653 |
|
552 |
460 |
$11K |
| 73140 |
|
356 |
319 |
$11K |
| 87641 |
|
414 |
361 |
$11K |
| 83550 |
|
1,601 |
1,331 |
$10K |
| 87147 |
|
1,907 |
891 |
$10K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
33 |
24 |
$9K |
| 80076 |
|
1,533 |
1,295 |
$9K |
| 86140 |
|
2,442 |
1,899 |
$9K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
231 |
142 |
$9K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,392 |
1,114 |
$9K |
| 80050 |
General health panel |
1,228 |
1,181 |
$9K |
| 83540 |
|
1,881 |
1,546 |
$9K |
| 83970 |
|
296 |
250 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
324 |
196 |
$9K |
| 86618 |
|
823 |
496 |
$8K |
| 82746 |
|
844 |
687 |
$8K |
| 87807 |
|
883 |
690 |
$8K |
| 93970 |
|
90 |
78 |
$8K |
| 94729 |
|
257 |
206 |
$8K |
| 86003 |
|
145 |
110 |
$8K |
| 94726 |
|
241 |
192 |
$7K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,318 |
2,373 |
$7K |
| 81003 |
|
7,496 |
5,869 |
$7K |
| 88304 |
|
312 |
248 |
$7K |
| 87205 |
|
2,234 |
1,845 |
$7K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
493 |
212 |
$7K |
| 82784 |
|
726 |
580 |
$7K |
| 83516 |
|
576 |
495 |
$7K |
| 93320 |
|
112 |
94 |
$7K |
| 93325 |
|
112 |
94 |
$7K |
| 85379 |
|
990 |
794 |
$6K |
| 82570 |
|
1,735 |
1,413 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
790 |
687 |
$6K |
| 73502 |
|
201 |
157 |
$6K |
| 86762 |
|
575 |
463 |
$6K |
| 70498 |
|
29 |
24 |
$6K |
| 86706 |
|
758 |
586 |
$6K |
| 86592 |
|
1,813 |
1,501 |
$6K |
| 83605 |
|
914 |
658 |
$6K |
| 86038 |
|
601 |
513 |
$5K |
| 86900 |
|
2,454 |
1,855 |
$5K |
| 85651 |
|
2,080 |
1,656 |
$5K |
| 87522 |
Neg quan hep c or qual rna |
158 |
119 |
$5K |
| 86901 |
|
2,452 |
1,854 |
$5K |
| 88341 |
|
109 |
83 |
$5K |
| 83789 |
|
375 |
313 |
$5K |
| 82043 |
|
1,213 |
1,005 |
$4K |
| 45388 |
|
14 |
12 |
$4K |
| 96367 |
|
34 |
25 |
$4K |
| 84403 |
|
190 |
153 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
260 |
213 |
$4K |
| 86364 |
|
118 |
83 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,449 |
5,329 |
$4K |
| 12001 |
|
62 |
51 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,818 |
1,251 |
$4K |
| 84100 |
|
1,323 |
874 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
38 |
33 |
$4K |
| 80074 |
|
113 |
94 |
$4K |
| 84153 |
|
348 |
282 |
$4K |
| 99219 |
|
16 |
14 |
$3K |
| 97165 |
|
92 |
69 |
$3K |
| 73080 |
|
110 |
95 |
$3K |
| 87640 |
|
208 |
181 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,093 |
2,816 |
$3K |
| 82550 |
|
784 |
566 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
742 |
572 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
542 |
422 |
$3K |
| 82248 |
|
836 |
630 |
$3K |
| 71101 |
|
64 |
49 |
$3K |
| 93976 |
|
33 |
27 |
$3K |
| 87210 |
|
1,002 |
848 |
$3K |
| 76870 |
|
36 |
28 |
$2K |
| 82805 |
|
80 |
57 |
$2K |
| 93246 |
|
34 |
26 |
$2K |
| 77080 |
|
29 |
24 |
$2K |
| 90715 |
|
150 |
133 |
$2K |
| 97802 |
|
39 |
25 |
$2K |
| 93923 |
|
30 |
26 |
$2K |
| 82947 |
|
545 |
481 |
$2K |
| 81025 |
|
351 |
279 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
837 |
592 |
$1K |
| 97750 |
|
89 |
68 |
$1K |
| 97803 |
|
130 |
96 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,332 |
1,565 |
$1K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
41 |
28 |
$1K |
| 85652 |
|
674 |
513 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,203 |
2,382 |
$1K |
| 82565 |
|
345 |
302 |
$1K |
| 96368 |
|
29 |
25 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,380 |
844 |
$1K |
| 86708 |
|
126 |
99 |
$1K |
| 97010 |
|
505 |
172 |
$1K |
| 84146 |
|
60 |
48 |
$1K |
| 51701 |
|
72 |
50 |
$969.14 |
| 84480 |
|
88 |
77 |
$947.56 |
| 86704 |
|
106 |
90 |
$932.27 |
| 84156 |
|
337 |
277 |
$892.45 |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$856.15 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
792 |
479 |
$722.21 |
| 88312 |
|
30 |
25 |
$600.43 |
| 82785 |
|
40 |
26 |
$598.30 |
| 86431 |
|
132 |
120 |
$574.97 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,216 |
878 |
$534.26 |
| 51798 |
|
33 |
26 |
$521.54 |
| 73090 |
|
20 |
13 |
$501.45 |
| 84402 |
|
24 |
15 |
$489.97 |
| 86787 |
|
44 |
38 |
$478.89 |
| 85007 |
|
349 |
192 |
$474.77 |
| 82950 |
|
172 |
135 |
$461.62 |
| 72070 |
|
16 |
14 |
$415.79 |
| 82105 |
|
35 |
32 |
$398.40 |
| 83615 |
|
81 |
54 |
$378.62 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
155 |
137 |
$375.49 |
| 80164 |
|
51 |
36 |
$355.25 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
606 |
486 |
$318.40 |
| L4361 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf |
14 |
12 |
$309.73 |
| 87015 |
|
60 |
39 |
$306.66 |
| 85046 |
|
126 |
103 |
$306.43 |
| 87106 |
|
40 |
36 |
$295.69 |
| 87427 |
|
13 |
12 |
$278.73 |
| 84481 |
|
21 |
12 |
$270.37 |
| 88142 |
|
17 |
15 |
$262.85 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
13 |
$259.62 |
| 82150 |
|
63 |
52 |
$237.73 |
| J2060 |
Injection, lorazepam, 2 mg |
541 |
343 |
$235.42 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
392 |
362 |
$235.39 |
| 80178 |
|
54 |
38 |
$231.94 |
| 82803 |
|
21 |
13 |
$216.98 |
| 84425 |
|
14 |
13 |
$179.06 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
58 |
43 |
$171.89 |
| 84550 |
|
51 |
42 |
$165.32 |
| 81015 |
|
79 |
69 |
$158.66 |
| 82247 |
|
40 |
25 |
$157.93 |
| J1644 |
Injection, heparin sodium, per 1000 units |
190 |
82 |
$124.28 |
| 87045 |
|
14 |
13 |
$123.51 |
| 84436 |
|
26 |
14 |
$118.61 |
| 83655 |
|
12 |
12 |
$115.50 |
| 86141 |
|
12 |
12 |
$115.07 |
| 87046 |
|
27 |
25 |
$108.44 |
| 81005 |
|
66 |
42 |
$105.22 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
168 |
105 |
$97.34 |
| 83525 |
|
14 |
12 |
$96.45 |
| 99217 |
|
14 |
13 |
$73.56 |
| 84520 |
|
28 |
25 |
$68.09 |
| 82977 |
|
12 |
12 |
$67.45 |
| 86308 |
|
14 |
12 |
$53.80 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
226 |
156 |
$30.46 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
16 |
13 |
$28.18 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
17 |
13 |
$22.18 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
32 |
30 |
$17.65 |
| 85018 |
|
13 |
12 |
$17.62 |
| J1630 |
Injection, haloperidol, up to 5 mg |
13 |
12 |
$8.75 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
37 |
26 |
$7.56 |
| 80354 |
|
197 |
169 |
$5.36 |
| 80348 |
|
197 |
169 |
$5.36 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
272 |
167 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
288 |
176 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
18 |
14 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
17 |
14 |
$0.00 |